A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2011
08/11/2011	CA2788835A1 The use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with inhibitors of calcineurin or inhibitors of the mammalian target of rapamycin (mtor) complexes
08/11/2011	CA2788824A1 Chlorotoxin polypeptides and conjugates and uses thereof
08/11/2011	CA2788689A1 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
08/11/2011	CA2788347A1 Disruptive polymer micelle composition
08/11/2011	CA2782444A1 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
08/11/2011	CA2731282A1 Anti-fatigue composition
08/11/2011	CA2692371A1 Anti-fatigue composition
08/10/2011	EP2354791A1 Immunocytokines with modulated selectivity
08/10/2011	EP2354230A1 Neisseria meningitidis surface protein
08/10/2011	EP2354155A2 Fusion Proteins for Treatment of CNS
08/10/2011	EP2354153A2 Stable peptide mimetic of HIV gp41 fusion intermediate
08/10/2011	EP2354152A1 Peptide antagonist of interleukin-15 activity
08/10/2011	EP2354149A1 Molecules with extended half-lives, compositions and uses thereof
08/10/2011	EP2353651A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders
08/10/2011	EP2353607A1 Use of disintegrin domain of an adamalysin for the treatment of psoriasis
08/10/2011	EP2353606A2 Compositions and methods for the treatment of CNS injuries
08/10/2011	EP2353600A1 Agent used in cases of lactase deficiency and lactose intolerance
08/10/2011	EP2353588A1 A sustained preparation of factor IX
08/10/2011	EP2353547A1 Agent for regenerating tympanic membrane or external auditory canal
08/10/2011	EP2353012A1 Biomarkers and methods for detecting and treating spinal and joint pain
08/10/2011	EP2352840A2 Targets for treatment of chlamydial infections
08/10/2011	EP2352823A1 Porphobilinogen deaminase gene therapy
08/10/2011	EP2352753A1 Biocidal fusion peptide comprising ll-37
08/10/2011	EP2352746A1 Bioactive compounds
08/10/2011	EP2352517A1 Methods and compositions for treating complement-associated disorders
08/10/2011	EP2352515A1 Method for the treatment of hemophilia
08/10/2011	EP2352514A1 Methods and kits for treating disease by administering insulin-like growth factor binding protein-2
08/10/2011	EP2352513A1 Treating diabetes melitus using insulin injections with less than daily injection frequency
08/10/2011	EP2352512A1 Mechanism of neuromedin u action and uses thereof
08/10/2011	EP2352511A2 Neuropeptide-2-receptor (y-2r) agonists and uses thereof
08/10/2011	EP2352510A1 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
08/10/2011	EP2352509A1 Hla-g proteins and pharmaceutical uses thereof
08/10/2011	EP2352508A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
08/10/2011	EP2352507A1 Peptidomimetic macrocycles with improved properties
08/10/2011	EP2352504A2 Treatment of proliferative disorders with a death receptor agonist
08/10/2011	EP2352503A1 Role of soluble upar in the pathogenesis of proteinuric kidney disease
08/10/2011	EP2352496A1 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
08/10/2011	EP2352394A2 Improved peptide availability
08/10/2011	EP1988914B1 Combination of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
08/10/2011	EP1969004B1 Compositions comprising an acylated insulin and zinc and method of making the said compositions
08/10/2011	EP1572743B1 Peptides and their use for the treatment of hiv infections
08/10/2011	EP1509617B1 Light emitting microorganisms and viruses for diagnosis of diseases associated with wounded or inflamed tissue
08/10/2011	EP1507554B1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
08/10/2011	EP1465653B1 Therapeutic application of g-csf
08/10/2011	EP1461079B1 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
08/10/2011	EP1432790B1 Regulation of cytotrophoblast cell differentiation and cell migration
08/10/2011	EP1430157B1 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/10/2011	EP1411967B1 Blocking peptide for inflammatory cell secretion
08/10/2011	EP1358206B1 Peptide-based compounds
08/10/2011	EP1309340B1 High mannose proteins and methods of making high mannose proteins
08/10/2011	EP1190074B1 Recombinant anti-cd40 antibody and uses thereof
08/10/2011	EP1135513B2 Adenovirus-mediated gene therapy
08/10/2011	EP1068296B1 Compositions for eliciting an immune response to a telomerase antigen
08/10/2011	EP0935001B2 Novel vegf-like factors
08/10/2011	CN1990037B Thymosin alpha1 active fragment and polyethylene glycol derivative thereof
08/10/2011	CN1985988B Novel medicine composition for treating hepatic diseases
08/10/2011	CN1984924B Methods for increasing conjugation of protein and polyethylene glycol (PEG)
08/10/2011	CN1980948B Treatment of diseases and conditions mediated by increased phosphorylation
08/10/2011	CN1870894B Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes
08/10/2011	CN102149827A Use of MiR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
08/10/2011	CN102149725A CBP501 -derived agents and methods based thereon for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
08/10/2011	CN102149432A Organoarsenic compounds and methods for the treatment of cancer
08/10/2011	CN102149403A Methods of treatment utilizing binding proteins of the interleukin-21 receptor
08/10/2011	CN102149402A Cyclosporin derivatives for treating ocular and dermal diseases and conditions
08/10/2011	CN102149401A Micro-RNA-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma
08/10/2011	CN102149391A Compositions and methods for treatment of neoplastic disease
08/10/2011	CN102146364A Serine protease isolated from the venom of bombus ignitus as fibrinogenolytic and fibrinolytic enzymes
08/10/2011	CN102146133A Long-acting recombinant interferon and method for constructing, expressing and purifying recombinant expression engineering bacteria thereof
08/10/2011	CN102146132A Active polypeptide with antagonistic chemotactic factor receptor CCR5 and preparation method and application thereof
08/10/2011	CN102146122A Process for producing medicament with uterine contraction effect
08/10/2011	CN102146121A Process for producing antagonist medicament containing OXT (oxytocin)
08/10/2011	CN102145178A PEG interleukin 15
08/10/2011	CN102145164A IAPP (Islet Amyloid Polypeptide) analog injection with better stability
08/10/2011	CN102145163A Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity
08/10/2011	CN102145162A Injection of medicine for treating premature delivery
08/10/2011	CN102145161A Application of integrin blocking agent in preparing medicament for treating tumors
08/10/2011	CN102145160A Controlled-release implanting preparation used for injecting LHRH (luteinizing hormone releasing hormone) antagonist
08/10/2011	CN102144980A LHRH (luteinizing hormone-releasing hormone antagonist) lyophilized powder injection with improved stability
08/10/2011	CN102144977A Preparation method of growth hormone nanoparticles with biological activity
08/10/2011	CN102144976A Method for preparing insulin dry powder for oral administration by using micro capsulation technology
08/10/2011	CN102144974A Liposome preparation for anticoagulant thrombolytic difunctional fusion protein and preparation method thereof
08/10/2011	CN102144968A Oral suspension of liposome-encapsulated insulin lyophilized preparation and preparation process thereof
08/10/2011	CN102144965A More-stable carbetocin acetate injection
08/10/2011	CN101648993B Small peptide A with antibacterial and antitumor functions and applications thereof
08/10/2011	CN101481412B Polypeptide with antineoplastic function, encoding gene and use thereof
08/10/2011	CN101434962B Japanese blood fluke (Chinese mainland strain) tyrosine kinase TK4 conserved region gene, and cloning expression method and use thereof
08/10/2011	CN101418329B Preparation method of rapeseed proteolysis peptides based on pulse ultrasonic technology and use thereof
08/10/2011	CN101411864B Thymopentin dry powder formulation and preparation method thereof
08/10/2011	CN101372507B Signal conotoxin mutant polypeptides compound lt14a-7, preparation and use thereof
08/10/2011	CN101269211B Shuangtang high calcium medicinal granule and preparation technique
08/10/2011	CN101137669B Method for cleaning marine collagen and the treatment thereof to form porous sponges
08/10/2011	CN101054408B Method for separating housefly secretion type antibacterial peptide, product and application thereof
08/09/2011	US7994362 Histone deacetylases, and uses related thereto
08/09/2011	US7994329 Growth hormone secretagogue receptor type 1A agonists
08/09/2011	US7994309 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent
08/09/2011	US7994301 Modulators of body weight, corresponding nucleic acids and proteins
08/09/2011	US7994294 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
08/09/2011	US7994292 MU-1, member of the cytokine receptor family
08/09/2011	US7994289 Humanized anti-CD3 antibodies
08/09/2011	US7994288 Allergenic proteins of natural rubber latex, their production and use in assays

1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 3163